GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    National Library of Serbia ; 2004
    In:  Srpski arhiv za celokupno lekarstvo Vol. 132, No. 11-12 ( 2004), p. 385-389
    In: Srpski arhiv za celokupno lekarstvo, National Library of Serbia, Vol. 132, No. 11-12 ( 2004), p. 385-389
    Abstract: U periodu od 1995. do 2003. godine na Institutu za neurologiju Klinickog centra Srbije u Beogradu ispitano je 30 bolesnika sa grafospazmom i distonijama koje su vezane za specificne zadatke (task-specific dystonia). Ispitanici su na pocetku bolesti imali 34,1 ?11,4 godina (13-58). Bilo je20muskaraca i 10 zena. Ni kod jednog bolesnika nije bilo anamneze o traumi na mestu na kome ce se kasnije razviti bolest. Dva bolesnika su imala obolele srodnike, a kod jednog je utvrdjena mutacija DYT1. Posturalni tremor je imalo osam bolesnika. Osam ispitanika su bili daktilografi, cetvoro muzicari, dok su se ostali bavili zanimanjima koja nismo mogli dovesti u vezu s razvojem bolesti. Dvanaest bolesnika je imalo tzv. prosti grafospazam (40%), desetoro progresivni grafospazam (33,3%), dok je kod ostalih dijagnostikovan distonijski grafospazam. Tin grafospazma nije bio u korelaciji ni sa jednim od ispitivanih parametara, osim sa godinama ispitanika na pocetku bolesti, tako da je uoceno ranije javljanje grafospazma u odnosu na ostale oblike bolesti, dok su se distonijski i progresivni grafospazam javljali nesto kasnije. Kod nasih bolesnika nije utvrdjena depresivnost, anksioznost ili opsesivnost.
    Type of Medium: Online Resource
    ISSN: 0370-8179 , 2406-0895
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2004
    detail.hit.zdb_id: 2577665-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 72, No. 12 ( 2015), p. 1069-1073
    Abstract: Background/Aim. Botulinum toxin (BTX) irreversibly inhibits presynaptic acetylcholine release with subsequent relaxation of abnormally contracting muscles. It is an effective and well tolerated treatment with long-term benefit in a variety of movement disorders and other neurological and non-neurological disturbances. The aim of our study was to present our experience with BTX type A in treatment of different forms of focal dystonias. ?ethods. ? hundred of patients with different focal dystonias (spastic torticollis, blepharospasm and graphospasm) from the Botulinum Toxin Outpatients Department, Clinic for Neurology, Clinical Center of Serbia, were included in the study. All the patients were examined and rated at baseline visit prior to BTX application and on the following visit, after 3-4 months, using self-assessment improvement questionnaire and standardized rating scales. Results. The improvement of ? 50% was presented in 68.2% of all (199) the analyzed applications. Independent predictors of good response to the therapy (improvement ? 50%) were male sex (p = 0.011), the presence of sensory trick (p = 0.013) and the total number of BTX applications (p = 0.002). The patients with spastic torticollis and blepharospasm showed a statistically significantly better BTX effect (improvement 57.3 ? 27.5% and 54.1 ? 28.3%), respectively than the graphospasm group (26.7 ? 25.6%). Most of the patients did not have therapy complications (81.4% and 72% in two applications). Side effects in the remaining patients (muscle weakness, dysphagia, ptosis, double vision, neck weakness and lacrimal dysfunction) lasted for 28.3 ? 18.6 days after the first treatment and 32.5 ? 36.2 days after the second one. Conclusion. BTX is safe and highly effective in long-term treatment of patients with different forms of focal dystonia, with only mild and well-tolerated side-effects.
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2015
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 64, No. 10 ( 2007), p. 671-675
    Abstract: Uvod/Cilj. Spazmodicna disfonija (SD) je onesposobljavajuci poremecaj govora koji nastaje kao posledica distonicke kontrakcije glasnica, cije epizodicno javljanje u larinksnim misicima dovodi do prekidanja vokalne funkcije. Kvalitet zivota ovih bolesnika znacajno je narusen, a medikamentna i hirurska terapija su se pokazale neadekvatnim i neuspesnim, te nisu obezbedjivale kontinuirano poboljsanje. Tek se primena botulinskog toksina u glasnice pokazala efikasnom, a poboljsanje je konstatovano kod 80?100% bolesnika. Cilj ovog rada bio je da se proceni efikasnost primene botulinskog toksina u lecenju bolesnika sa spazmodicnom disfonijom. Metode. Grupu bolesnika cinilo je 10 obolelih sa adduktorskom formom spazmodicne disfonije. Posle postavljanja dijagnoze kod svih bolesnika injiciran je botulinski toksin u jednu ili obe glasnice u dozi 12-16 U u svaku glasnicu. U nasoj studiji koristili smo indirektoskopsku tehniku injiciranja botulinskog toksina. Perceptivna analiza glasa i govora pre i posle instilacije botulinskog toksina vrsena je prema strukturisanoj Skali patoloskih karakteristika glasa i govora kod spazmodicne disfonije. Rezultati. Kod vecine nasih bolesnika primena botulinskog toksina dovela je do subjektivnog poboljsanja i podizanja kvaliteta zivota, sto su sami bolesnici procenili kao znacajno (t = 3,562; p = 0,006). Perceptivnom analizom glasa i govora posle instilacije botulinskog toksina kod nasih bolesnika ustanovljene su statisticki znacajne promene parametara kao sto su napetost, promena visine glasa i registar glasa (t = 3,161; p = 0,012). Zakljucak. I pored nedvosmisleno znacajnog poboljsanja fonacije, dalja restitucija funkcije zahteva individualnu vokalnu terapiju i psihoterapiju. Neophodna su dalja istrazivanja koja bi definisala standardizovanu terapijsku proceduru u lecenju bolesnika sa spazmodicnom disfonijom, a koja sigurno podrazumeva multidisciplinarni pristup u dijagnostici, terapiji i evaluaciji efekata terapije.
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2007
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    National Library of Serbia ; 2009
    In:  Military Medical and Pharmaceutical Journal of Serbia Vol. 66, No. 1 ( 2009), p. 9-12
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 66, No. 1 ( 2009), p. 9-12
    Abstract: Uvod/Cilj. Botulinski toksin A (BTX-A) blokira oslobadjanje acetilholina iz motornih i autonomnih nervnih zavrsetaka, te moze znatno da umanji stvaranje pljuvacke kada se ordinira intraglandularno. Cilj ove studije bio je da se utvrde efekti primene BTX-A u lecenju sijaloreje kod raznih neuroloskih poremecaja. Metode. Ovom studijom bilo je obuhvaceno 19 konsekutivnih bolesnika sa znacajnom sijalorejom izazvanom razlicitim neuroloskim bolestima. Od tog broja 13 bolesnika je bilo sa Parkinsonovom bolesti, dva sa pantotenat kinaza-udruzenom neurodegeneracijom, dva sa multiplom sistemskom atrofijom, jedan sa Wilson-ovom bolesti i jedan bolesnik sa postoperativnom sijalorejom. Botulinski toksin A (Dysport?, Ipsen Pharma) injektovan je u parotidne zlezde kod bolesnika sa (n = 7) i bez (n = 12) ultrazvucnog navodjenja. Svi bolesnici ocenjivani su pre i posle tretmana u nedeljnim intervalima uz primenu dela UPDRS skale koji se odnosi na hipersalivaciju (Unified Parkinson's Disease Rating Scale - UPDRS, Part II Activity of Daily Living). Rezultati. Ukupno 13 bolesnika (68%) saopstilo je povoljno dejstvo injektovanja BTX-A, dok je sest bolesnika (32%) ostalo bez ikakve reakcije. Ocene stepena sijaloreje pre i posle tretmana bile su 3,1 ? 0,1 (opseg 2-4) i 1,8 ? 0,1 (opseg 0-3), respektivno (t = 5,636; p 〈 0,001). Nije bilo razlike u magnitudi reakcije izmedju grupa sa (t = 4,500; p = 0,004) i bez (t = 3,674; p = 0,005) ultrazvucnog upravljanja mestima injektovanja. Nezeljeni efekti zabelezeni su kod pet bolesnika (26%). Zakljucak. Injektiranje botulinskog toksina A u lako pristupacne parotidne zlezde, bez potrebe za ultrazvucnim navodjenjem, bezbedno je i efikasno u lecenju sijaloreje kod razlicitih neuroloskih bolesti.
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2009
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 70, No. 5 ( 2013), p. 457-462
    Abstract: Background/Aim. Wilson?s disease (WD) is an autosomal-recessive disorder which is characterized with a marked clinical heterogeneity. The gene responsible for WD is located in 13q14.3 chromosome, contains 21 exons and codes for copper specific transporting P-type adenosinetriphosphatase (ATPase) (ATP7B). Mutations in ATP7B gene change biosynthetic and transporting role of ATPase in cell leading to damaged billiary excretion of copper and its accumulation in the liver, brain, cornea and other tissues. Until now, it has been described more than 400 mutations in ATP7B gene with characteristic geographic distribution. The aim of this study was to assess the spectrum of mutations of ATP7B gene on a large number of patients in Serbian population and to make a correlation between particular genotypes and specific phenotypes. Methods. Eighty-six consecutive patients with WD from WD Clinical Research programme were included in this study. Genetic analysis was performed by direct gene sequencing method. Results. Mutations in ATP7B gene were found in 93% analyzed patients (81.4% of all alleles analyzed). Thirteen mutations were identified, one of which (G998E) was the novel one, so far undescribed in the literature. The most frequent mutation in our population was H1069Q, which was present in 38.4% patients, and the second most frequent mutation was 2304-2305insC (11.6%). Also, a great number of gene polymorphisms of DNA sequences, which do not disturb the ATP7B gene function, was identified. Although neurological form of the disease was more frequent in the group of homozygous for H1069Q and the group of non- H1069Q carriers, there was no statistically significant difference between the groups. Conclusion. Our research showed that genetic diagnosis of WD can be done in 80% of cases by analysis of 5 most common mutations in our population, which facilitate diagnosis significantly. There was no correlation between different genotypes and specific phenotypic features of WD, the presence of psychiatric disturbances and cognitive deterioration.
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2013
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    National Library of Serbia ; 2017
    In:  Military Medical and Pharmaceutical Journal of Serbia Vol. 74, No. 10 ( 2017), p. 921-926
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 74, No. 10 ( 2017), p. 921-926
    Abstract: Background/Aim. Levodopa, the precursor of dopamine, is a substitute therapy for Parkinson''s disease. Long-term application of levodopa causes fluctuation in motor response and the occurrence of involuntary movements or dyskinesia. The aim of this study was to assess the risk factors for dyskinesia in Parkinson?s disease (PD) patients undergoing treatment with levodopa. Methods. We included 177 consecutive outpatients with PD, who had been undergoing treatment for at least six months. A semi-structured interview was used to collect demo-graphic and clinical data as well as a number of clinical scales. Results. Patients with dyskinesia (n = 90) were younger at dis-ease onset and had longer disease duration. They had higher Unified Parkinson''s Disease Rating Scale (UPDRS) scores and more frequently had other motor complications, such as wearing-off and freezing of gait, as well as non-motor ones, such as psychosis. They took higher levodopa doses and levodopa equivalent doses and were on levodopa therapy for a longer period of time. Multivariate analysis yielded that in-dependent risk factors for dyskinesia were: disease duration of longer than 10 years
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2017
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Neurological Sciences, Springer Science and Business Media LLC, Vol. 38, No. 8 ( 2017-8), p. 1415-1421
    Type of Medium: Online Resource
    ISSN: 1590-1874 , 1590-3478
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2017
    detail.hit.zdb_id: 1481772-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    National Library of Serbia ; 2006
    In:  Military Medical and Pharmaceutical Journal of Serbia Vol. 63, No. 10 ( 2006), p. 861-866
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 63, No. 10 ( 2006), p. 861-866
    Abstract: Uvod/Cilj. Multipla sistemska atrofija (MSA) je neurodegenerativna bolest centralnog nervnog sistema, koju karakterise kombinacija ekstrapiramidnog, cerebelarnog, piramidnog i autonomnog ostecenja. Ciljevi ovoga rada bili su: odredjivanje osnovnih klinickih specificnosti MSA u nasoj grupi obolelih, prikaz radioloskog i elektrofizioloskog profila bolesti i procena terapijskog odgovora na jednokratnu dozu levodope. Metode. Multipla sistemska atrofija dijagnostikovana je kod 29 bolesnika, kod kojih je bolest u momentu pregleda trajala prosecno pet godina. Protokol ispitivanja obuhvatao je anamnezu, kompletan neuroloski pregled, neurootoloska i neuroradioloska ispitivanja. Studijom su obuhvaceni bolesnici Instituta za neurologiju Klinickog centra Srbije u periodu od 1996. do 2001. godine koji su ispunjavali klinicke i dijagnosticke kriterijume za mogucu i verovatnu MSA. Rezultati. Simptomi autonomne disfunkcije nadjeni su kod 93,1% obolelih; ekstrapiramidni poremecaji, kod 60% simetricni na pocetku bolesti, vidjeni su kod 89,3%. Terapijski odgovor na levodopu bio je slab do umeren. Cerebelarni sindrom je zabelezen kod 63% bolesnika, a piramidni znaci kod 78,7%. Kod bolesnika nije bilo kognitivnih ostecenja (MMS 〉 24). Na kompjuterizovanoj tomografiji i nuklearnoj magnetnoj rezonanciji nadjene su kod vecine cerebelarna atrofija, umerena atrofija mozdanog stabla i difuzna korteksna atrofija. Zakljucak. Zbog nepreciznosti dopunskih dijagnostickih procedura pri izdvajanju obolelih sa MSA, neophodno je dobro poznavanje klinickih specificnosti obolelih, cemu doprinose i rezultati ovog istrazivanja.
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2006
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    National Library of Serbia ; 2014
    In:  Military Medical and Pharmaceutical Journal of Serbia Vol. 71, No. 4 ( 2014), p. 346-351
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 71, No. 4 ( 2014), p. 346-351
    Abstract: Background/Aim. Dysautonomia appears in almost all patients with Parkinson?s disease (PD) in a certain stage of their condition. The aim of our study was to detect the development and type of autonomic disorders, find out the factors affecting their manifestation by analyzing the potential association with demographic variables related to clinical presentation, as well as the symptoms of the disease in a PD patient cohort. Methods. The patients with PD treated at the Clinic of Neurology in Belgrade during a 2-year period, divided into 3 groups were studied: 25 de novo patients, 25 patients already treated and had no long-term levodopa therapy-related complications and 22 patients treated with levodopa who manifested levodopa-induced motor complications. Simultaneously, 35 healthy control subjects, matched by age and sex, were also analyzed. Results. Autonomic nervous system malfunction was defined by Ewing diagnostic criteria. The tests, indicators of sympathetic and parasympathetic nervous systems, were significantly different in the PD patients as compared with the controls, suggesting the failure of both systems. However, it was shown, in the selected groups of patients, that the malfunction of both systems was present in two treated groups of PD patients, while de novo group manifested only sympathetic dysfunction. For this reason, the complete autonomic neuropathy was diagnosed only in the treated PD patients, while de novo patients were defined as those with the isolated sympathetic dysfunction. The patients with the complete autonomic neuropathy differed from the subjects without such neuropathy in higher cumulative and motor unified Parkinson?s disease rating score (UPDRS) (p 〈 0.01), activities of daily living scores (p 〈 0.05), Schwab-England scale (p 〈 0.001) and Hoehn-Yahr scale. There was no difference between the patients in other clinical-demographic characteristics (sex, age at the time of diagnosis, actual age, duration of disease, involved side of the body, pain and freezing), but mini mental status (MMS) score and Hamilton depression and anxiety rating scale were significantly lower (p 〈 0.05). Conclusion. Our results confirm a high prevalence of autonomic nervous system disturbances among PD patients from the near onset of disease, with a predominant sympathetic nervous system involvement. The patients who developed complete autonomic neuropathy (both sympathetic and parasympathetic) were individuals with considerable level of functional failure, more severe clinical presentation and the existing anxiety and depression.
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2014
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    National Library of Serbia ; 2012
    In:  Military Medical and Pharmaceutical Journal of Serbia Vol. 69, No. 9 ( 2012), p. 759-764
    In: Military Medical and Pharmaceutical Journal of Serbia, National Library of Serbia, Vol. 69, No. 9 ( 2012), p. 759-764
    Abstract: Background/Aim. Segmental dystonia is an abnormal movement, characterized by involuntary, sustained and repetitive muscular contractions, causing twisting and abnormal posturing of two or more adjacent body parts. It is not a life-reducing condition, but it deteriorates physical, mental and social functioning. The aim of the study was to define the basic demographic and clinical characteristics of patients with segmental dystonia and to estimate their quality of life. Methods. The study included patients treated at the Clinic for Neurology - Clinical Center of Serbia (Department for Involuntary Movements). The patients with idiopathic segmental dystonia fulfilled the following questionnaires: general questionnaire, standard questionnaire for estimation of the quality of life SF 36, a list of questionnaires related to disease, and social participation scales. Statistical analysis involving the methods of descriptive statistics and linear regression analysis was used for predictive values of the characteristics. Results. The study included 28 patients with segmental dystonia, the mean age of 53.1 ? 15.8 years. Analysis of SF 36 questionnaire item domains showed that patients with segmental dystonia had the lowest score in the domain of body pain (30.6 ? 28.2) and the highest in the domain of physical function (73.6 ? 19.6). Higher values of the scale of the disease severity (?= -0.526, 95% CI -4.719, -0.996; p = 0.0004) and Hamilton depression scale (?= - 0.498, 95% CI -1.295, -0.227; p = 0.0007) were more significant predictors of low quality of life. Higher value of the Leisure activities scale (?= 0.611, 95% CI 0.242, 0.772; p = 0.001) was a significant predictor of better quality of life. Conclusion. The most important predictors of low quality of life in patients with segmental dystonia were disease severity, low acceptance of illness, depression and low self-esteem.
    Type of Medium: Online Resource
    ISSN: 0042-8450 , 2406-0720
    Language: English
    Publisher: National Library of Serbia
    Publication Date: 2012
    detail.hit.zdb_id: 2169819-3
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...